| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |